Efficacy of a novel hemostatic adhesive powder in patients with upper gastrointestinal tumor bleeding

Abstract Background Gastrointestinal tumor bleeding remains a clinical challenge because it is difficult to treat with conventional endoscopic hemostatic options. Recently, an powder (UI-EWD) was developed and reported provide effective control of upper gastrointestinal bleeding. The aim current study evaluate the feasibility efficacy this novel in Methods A total 41 consecutive patients were included. UI-EWD applied all as auxiliary method salvage therapy or monotherapy during treatment. Hemostasis success rates, adverse event related UI-EWD, rates re-bleeding evaluated. Results In cases, application successful at sites. Immediate hemostasis occurred 40/41 (97.5%) patients, within 28 days 10 40 (22.5%) that achieved initial hemostasis. rate immediate for 100% (23/23). after 26.1% (6/23). No events associated encountered. Conclusions cases GI excellent produced promising results respect prevention re-bleeding. Based on these results, we suggest be considered even